Alzheimer's Disease Trial, Recruiting (NCT06679296)

Alzheimer's Disease Trial, Recruiting NCT06679296 Sponsor: First Affiliated Hospital of Wenzhou Medical University Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06679296 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are able to read, understand, and sign a consent form themselves, or have a legally authorised representative who can do this on their behalf.
People who are able to complete study assessments either on their own or with help from someone else.
People who are willing and able to take part in all study procedures, including tests to check how certain organs are working, brain wave recordings (EEG), a spinal fluid sample (lumbar puncture), and brain scans (MRI and PET).
People who are willing to attend follow-up visits as required by the study.

Who may not be able to join:

People who have a serious illness, such as a late-stage cancer or a severe autoimmune disease, that has reached a terminal stage at the time of joining the trial.
People who currently misuse alcohol, drugs, or other substances.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Weihong Song Prof., First Affiliated Hospital of Wenzhou Medical University

Phone: 86+13758710622

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06679296

Sponsor: First Affiliated Hospital of Wenzhou Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 86+13758710622

More information: https://clinicaltrials.gov/study/NCT06679296

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are able to read, understand, and sign a consent form themselves, or have a legally authorised representative who can do this on their behalf.
People who are able to complete study assessments either on their own or with help from someone else.
People who are willing and able to take part in all study procedures, including tests to check how certain organs are working, brain wave recordings (EEG), a spinal fluid sample (lumbar puncture), and brain scans (MRI and PET).
People who are willing to attend follow-up visits as required by the study.

Who may not be able to join:

People who have a serious illness, such as a late-stage cancer or a severe autoimmune disease, that has reached a terminal stage at the time of joining the trial.
People who currently misuse alcohol, drugs, or other substances.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

First Affiliated Hospital of Wenzhou Medical University

Registry

ClinicalTrials.gov

Start date

20 November 2024

Est. completion

31 December 2033

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Assessing the prevalence of cognitive impairment in China based on MMSE, MoCA and CDR.; Change in Alzheimer disease biomarkers over time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov